Estrogen patches: compare brands, costs and supply

What is an estrogen patch and how does it work?

Modern estradiol patches are matrix systems: the hormone is dissolved directly in the adhesive layer, so the patch is thin, flexible, and delivers a controlled dose per day. Standard strengths run 0.025 to 0.1 mg/day. You apply it to clean, dry skin on the lower abdomen or buttocks (not the breasts, per labeling), and rotate sites. The transdermal route matters clinically for one big reason: estrogen absorbed through the skin enters circulation directly instead of passing through the liver first, the way a swallowed pill does. That avoids the first-pass effect that drives up clotting factors, the mechanism behind the observational finding that transdermal estrogen carries lower venous-thromboembolism risk than oral. It also means steadier blood levels than the daily peak-and-trough of a pill. The trade-offs are mundane: skin irritation at the site, patches peeling in heat or heavy sweat, and pharmacy availability.

Sources: FDA-approved estradiol transdermal labeling via DailyMed (NIH); route-of-administration evidence per The Menopause Society 2022 hormone therapy position statement.

Which estrogen patch brands exist?

These are common brand names and an older brand you may still encounter in searches. Compare the application schedule and exact product; the dated supply notes do not guarantee stock. The full brand list links to recorded labels and marketing status.

Sources: product labeling via DailyMed; shortage status per the ASHP estradiol transdermal system entry dated August 12, 2026. Minivelle is a discontinued brand; its authorized generic remains listed. These supply notes are dated manufacturer reports. Ask your pharmacy about the exact strength and package you need.

Is generic the same as brand? (Dotti vs Vivelle-Dot)

Yes, in the way that matters. Dotti and Lyllana are FDA-approved generic estradiol transdermal systems referencing Vivelle-Dot, approved as therapeutically equivalent, same hormone, same delivery rate, same twice-weekly schedule. A pharmacist can check the FDA therapeutic-equivalence rating for the exact products and whether substitution is permitted for your prescription. Adhesives and backing materials differ; tell your clinician or pharmacist about skin reactions or a patch that repeatedly falls off. Second, equivalence doesn't help when the entire reference family is short: Vivelle-Dot, Dotti, and Lyllana doses have all appeared on the ASHP list in 2026, so "just take the generic" is frequently not an option at the counter. That's when switching schedule (to a once-weekly Climara-family patch) or switching route entirely becomes the conversation to have with your prescriber.

Source: FDA therapeutic-equivalence framework via Drugs@FDA (search any patch brand for its approval and equivalence records).

Why is my estrogen patch out of stock?

Increased demand has put pressure on supply. The FDA's September 3 update reports efforts to increase production and says availability varies by pharmacy and location. A national supply update cannot confirm stock at your dispensing pharmacy. Ask about your exact brand, strength and package, then contact your prescriber if it cannot be filled.

Which telehealth providers prescribe the patch, and at what price?

Our featured menopause providers that list a patch route, ordered by methodology score. During the shortage, the practical advantage of these platforms is a clinician one message away when a rewrite to a different brand, dose, or route is needed.

We earn a commission when readers sign up with some of these platforms. Disclosed on every page, never a factor in scores or order. Full comparison on the rankings; full price math on the cost page.

Patch, pill, or gel: how do they compare?

All three deliver systemic estradiol; the differences are route and ritual. Patch: steady transdermal delivery, once/twice-weekly, the lower-observed clot-risk route, currently supply-constrained. Pill: daily dosing, with first-pass liver metabolism; oral and transdermal estrogen have different risk considerations. Gel or spray:transdermal like the patch, daily application, no adhesive issues. FDA-approved gel and spray products exist; your prescriber must determine whether a switch fits your medical history and choose the dose. Availability requires a pharmacy check. The Menopause Society's position statement treats route selection as an individualized decision based on your risk profile and preference, which in plain English means: all three are legitimate, and the right one is the one you'll actually use consistently and can actually fill.

Source: The Menopause Society 2022 hormone therapy position statement.